Down-regulation of a polynucleotide encoding a Sou2 sorbitol utilization protein to modify lipid production in microbial cells

US9441209B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9441209-B2
Application numberUS-201514660229-A
CountryUS
Kind codeB2
Filing dateMar 17, 2015
Priority dateDec 21, 2012
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant microbial cell comprising a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein selected from the group consisting of Aspergillus niger, Bifidobacterium dentium, Candida albicans, Candida dubliniensis, Candida orthopsilosis, Candida parapsilosis, Cordyceps militaris, Debaryomyces hansenii, Enterobacter hormaechei, Gaeumannomyces graminis, Glarea lozoyensis, Lodderomyces elongisporus, Magnaporthe oryzae, Metarhizium acridum, Metarhizium anisopliae, Mycobacterium smegmatis, Neurospora crassa, Neurospora tetrasperma, Paracoccidioides brasiliensis, Penicillium chrysogenum, Scheffersomyces stipitis, Uncinocarpus reesii, Verticillium dahliae , and Yarrowia lipolytica , wherein said down-regulation decreases the total amount of sugar alcohols produced by the microbial cell, as compared to a suitable control cell. 2. The recombinant microbial cell of claim 1 , wherein said down-regulation is due to a mutation of said endogenous polynucleotide sequence. 3. The recombinant microbial cell of claim 2 , wherein said mutation is selected from the group consisting of a substitution, deletion and insertion. 4. The recombinant microbial cell of claim 3 , wherein said mutation is a deletion that removes (i) one or more nucleotides from an open reading frame encoding said Sou2 sorbitol utilization protein, and/or (ii) one or more nucleotides of a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame. 5. The recombinant microbial cell of claim 3 , wherein said mutation is an insertion that occurs within (i) an open reading frame encoding said Sou2 sorbitol utilization protein, or (ii) a non-protein-coding sequence located within 500 base pairs of the 5′-end of said open reading frame. 6. The recombinant microbial cell of claim 1 , wherein said sugar alcohols comprise arabitol or mannitol. 7. The recombinant microbial cell of claim 1 , wherein said microbial cell is an oleaginous yeast cell. 8. The recombinant microbial cell of claim 7 , wherein said oleaginous yeast is a Yarrowia lipolytica cell. 9. The recombinant microbial cell of claim 8 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10. 10. The recombinant microbial cell of claim 8 , wherein said endogenous polynucleotide sequence comprises a nucleotide sequence that is at least 95% identical to SEQ ID NO:9. 11. The recombinant microbial cell of claim 1 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 90% identical to SEQ ID NO:10. 12. The recombinant microbial cell of claim 11 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 95% identical to SEQ ID NO:10. 13. The recombinant microbial cell of claim 12 , wherein the Sou2 sorbitol utilization protein comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:10.

Assignees

Inventors

Classifications

  • for yeasts other than Saccharomyces · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • Sorbose reductase (1.1.1.289) · CPC title

  • C12N9/0006Primary

    acting on CH-OH groups as donors (1.1) · CPC title

  • acting on NADH or NADPH (1.6) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9441209B2 cover?
Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decre…
Who is the assignee on this patent?
Du Pont
What technology area does this patent fall under?
Primary CPC classification C12N9/0006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).